Genzyme CorporationUsage: CAPRELSA is indicated for treating symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. It may be considered for indolent, asymptomatic, or slowly progressing cases after careful risk assessment.